Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
BostonGene is a pioneering biomedical software company committed to advancing and personalizing cancer diagnostics and treatment through AI-driven molecular and immune profiling. Their platform performs comprehensive, integrated analysis of genomic, transcriptomic, and proteomic data from patient tumors and blood. This enables oncologists to identify optimal therapy options, predict treatment response, and understand tumor biology at an unprecedented level. BostonGene's solutions aim to empower clinicians with actionable insights for better patient outcomes in oncology.
Serves as the central hub for corporate leadership, research and development, data science, bioinformatics, clinical operations management, and business development activities.
The facility houses state-of-the-art laboratories for sample processing and analysis, advanced computational infrastructure for its AI platform, and collaborative office spaces designed to foster innovation.
BostonGene fosters a dynamic and mission-driven work culture characterized by scientific rigor, collaboration across multidisciplinary teams, innovation, and a strong focus on translating complex biological data into clinically actionable insights for cancer patients.
Its location in the Greater Boston area provides access to a rich ecosystem of world-class academic institutions, research hospitals, a vibrant biotech industry, and a highly skilled talent pool.
BostonGene operates with a global footprint, providing its AI-driven molecular and immune profiling services to oncologists, hospitals, and pharmaceutical partners across North America, Europe, Asia, and the Middle East. Their platform supports decentralized data analysis for clinical trials and research collaborations worldwide, aiming to make personalized cancer care accessible globally.
150 Bear Hill Road, Suite 101
Waltham
MA
USA
Address: Technopark Skolkovo, Bolshoy Boulevard, 42, bld. 1, office 3.305
Supports global R&D efforts by tapping into a strong pool of technical and scientific expertise in the region, contributing to the continuous development and enhancement of BostonGene's analytical tools and AI algorithms.
Address: HaEshel St 7, Caesarea Industrial Park, Israel
Facilitates engagement with the local biotech ecosystem, supports clinical trial activities, and expands BostonGene's reach in the Middle East and European markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BostonGene' leadership includes:
BostonGene has been backed by several prominent investors over the years, including:
In the past year, BostonGene has focused on strengthening its leadership team with key appointments, particularly in medical and operational roles, to support its growth and expansion in the precision oncology market. No major publicly announced departures of C-suite executives were noted.
Discover the tools BostonGene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BostonGene commonly uses the email format combining the first initial and last name. For example, for an employee named Jane Doe, the email would likely be jdoe@bostongene.com. Variations might exist but this is the most prevalent.
first_initial_last@bostongene.com
Format
jdoe@bostongene.com
Example
90%
Success rate
PR Newswire • 2024-05-29
BostonGene presents new data at ASCO/SMO 2024 highlighting expanded utility of its AI-driven analytics platform in solid tumors and hematologic malignancies. The studies demonstrate the platform's ability to identify novel biomarkers, predict treatment response, and improve patient stratification....more
PR Newswire • 2024-01-09
BostonGene appoints Nathan Fowler, MD, a distinguished leader in lymphoma and oncology, as its Chief Medical Officer to spearhead the company's clinical development and medical affairs strategy....more
PR Newswire • 2023-11-01
BostonGene presented data at SITC 2023, showcasing the clinical utility of its AI-driven analytics in immuno-oncology. The findings highlighted the platform's ability to predict response to immunotherapy and identify novel therapeutic targets....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BostonGene, are just a search away.